Newsroom
Wednesday, 30 August 2023 06:41

LEKLI njofton se CUPROS L (D-penicillamine)

LEKLI sh.p.k njofton se CUPROS L (D- penicillamine) ka marrë Autorizimin për Tregtimin.

Detajet e deklaratës për shtyp

16/08/2023

LEKLI njofton se Agjencia Kombëtare e Bar...

Monday, 24 October 2022 06:52

KAHLERMID L (Lenalidomide) has granted the Marketing Authorization

Press Release Details

Oct 21,2022

LEKLI Announces that the National Agency for ...

Monday, 10 October 2022 13:52

MBROTIR L (Potassium iodide) has granted the Marketing Authorization

Press Release Details

Thursday, 05 May 2022 09:16

LEKLI sh.p.k continues to assist pediatricians with essential medications.

After several years of research work, our specialized staff was able to produce very important medications in the pediatric field.

Friday, 30 July 2021 11:51

LEKLI sh.p.k has completed the first stage of establishing the line of human drug production for producing Oral Solid Dosage (OSD) and Oral Liquid Dosage pharmaceutical forms for internal use.

LEKLI sh.p.k has completed the first stage of establishing the line of human drug production for producing Oral Solid Dosage (OSD) and Oral Liquid Dosage pharmaceutica...

Monday, 28 June 2021 11:13

LEKLI sh.p.k receives positive evaluations from the Minister of finance

The Minister of Finance and Economy, expressed her positive assessments through a post on her official page. Among other things, she writes that: “LEKLI sh.p.k is a ...

Page 1 of 2
1
LEKLI sh.p.k  Headquaters
Blv. Bajram Curri, Nd.172,
H.8, 1010 Tiranë, Albania
+355 42 374517
+355 68 900 5483
[email protected]
2
Production Facility
Autostrada Tiranë-Durrës,
Rr. Egnatia, Mbrapa Megatek,
Tiranë, Albania
+355 68 900 5486
3
LEKLI sh.p.k Tiranë
Rr. Reshit Petrela,
Pall.14, H.21, 1010,
Tiranë, Albania
+355 68 900 5488
4
LEKLI sh.p.k Durrës
Rr. Aleksandër Goga,
2001 Durrës, Albania
+355 68 900 5489
Don't have an account yet? Register Now!

Sign in to your account